Literature DB >> 16169676

CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.

Kyung Hwan Shin1, Tae Hyun Kim, Jung Keun Cho, Joo-Young Kim, Sung Yong Park, Sang-Yoon Park, Dae Yong Kim, Eui Kyu Chie, Hong Ryull Pyo, Kwan Ho Cho.   

Abstract

PURPOSE: To perform an intracavitary radiotherapy (ICR) plan comparison between the conventional point A plan (conventional plan) and computed tomography (CT)-guided clinical target volume-based plan (CTV plan) by analysis of the quantitative dose-volume parameters and irradiated volumes of organs at risk in patients with cervical cancer. METHODS AND MATERIALS: Thirty plans for 192Ir high-dose-rate ICR after 30-40-Gy external beam radiotherapy were investigated. CT images were acquired at the first ICR session with artifact-free applicators in place. The gross tumor volume, clinical target volume (CTV), point A, and International Commission on Radiation Units and Measurements Report 38 rectal and bladder points were defined on reconstructed CT images. A fractional 100% dose was prescribed to point A in the conventional plan and to the outermost point to cover all CTVs in the CTV plan. The reference volume receiving 100% of the prescribed dose (V(ref)), and the dose-volume parameters of the coverage index, conformal index, and external volume index were calculated from the dose-volume histogram. The bladder, rectal point doses, and percentage of volumes receiving 50%, 80%, and 100% of the prescribed dose were also analyzed.
RESULTS: Conventional plans were performed, and patients were categorized on the basis of whether the 100% isodose line of point A prescription dose fully encompassed the CTV (Group 1, n = 20) or not (Group 2, n = 10). The mean gross tumor volume (11.6 cm3) and CTV (24.9 cm3) of Group 1 were smaller than the corresponding values (23.7 and 44.7 cm3, respectively) for Group 2 (p = 0.003). The mean V(ref) for all patients was 129.6 cm(3) for the conventional plan and 97.0 cm3 for the CTV plan (p = 0.003). The mean V(ref) in Group 1 decreased markedly with the CTV plan (p < 0.001). For the conventional and CTV plans in all patients, the mean coverage index, conformal index, and external volume index were 0.98 and 1.0, 0.23 and 0.34, and 3.86 and 2.15, respectively. Statistical analysis showed that the conformal index and external volume index improved significantly with the CTV plan, and this improvement was more marked in Group 1. The mean values of the bladder and rectal point doses and volume fractions receiving 50%, 80%, and 100% of the reference dose did not differ between plans for all patients. The reduction in the mean rectal and bladder point doses and irradiated volumes for the CTV plan was statistically significant in Group 1.
CONCLUSION: Computed tomography-guided CTV planning of ICR is superior to conventional point A planning in terms of conformity of target coverage and avoidance of overdosed normal tissue volume. To ascertain the potential benefit of treatment outcome, ICR with image-guided three-dimensional plans will be pursued and correlated with the dose-volume parameters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16169676     DOI: 10.1016/j.ijrobp.2005.06.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

Review 1.  Consensus on 3D treatment planning in gynaecologic brachytherapy of the Radiation Oncology Spanish Society (SEOR) Brachytherapy Group.

Authors:  José Luis Guinot; José Pérez-Calatayud; Silvia Rodríguez; Alejandro Tormo; Vincente Crispán; Juan Carlos Menéndez
Journal:  Clin Transl Oncol       Date:  2010-03       Impact factor: 3.405

2.  Computed tomography-based three-dimensional dosimetry of intracavitary brachytherapy for cervical cancer.

Authors:  Koichi Wadasaki; Yoshio Monzen; Taichi Kurose; Hajime Okazaki; Mio Mito
Journal:  Jpn J Radiol       Date:  2010-12-30       Impact factor: 2.374

3.  Image-Guided High-Dose Rate Brachytherapy in Cervix Carcinoma Using Balloon Catheter and Belt Immobilization System.

Authors:  Qiyong Fan; Anamaria R Yeung; Robert Amdur; Richard Helmig; Justin Park; Jonathan Li; Darren Kahler; Chihray Liu; Bo Lu
Journal:  Technol Cancer Res Treat       Date:  2016-02-10

4.  Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.

Authors:  Radovan Vojtíšek; Emília Sukovská; Jan Baxa; Marie Budíková; Petra Kovářová; Jindřich Fínek
Journal:  Strahlenther Onkol       Date:  2019-07-15       Impact factor: 3.621

Review 5.  A review of recent developments in image-guided radiation therapy in cervix cancer.

Authors:  Azmat H Sadozye; Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

6.  Commissioning a CT-compatible LDR tandem and ovoid applicator using Monte Carlo calculation and 3D dosimetry.

Authors:  Justus Adamson; Joseph Newton; Yun Yang; Beverly Steffey; Jing Cai; John Adamovics; Mark Oldham; Junzo Chino; Oana Craciunescu
Journal:  Med Phys       Date:  2012-07       Impact factor: 4.071

7.  Sigmoid dose using 3D imaging in cervical-cancer brachytherapy.

Authors:  Caroline L Holloway; Marie-Lynn Racine; Robert A Cormack; Desmond A O'Farrell; Akila N Viswanathan
Journal:  Radiother Oncol       Date:  2009-08-06       Impact factor: 6.280

Review 8.  Image-based brachytherapy for cervical cancer.

Authors:  John A Vargo; Sushil Beriwal
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy.

Authors:  Swamidas V Jamema; Sherly Saju; Umesh Mahantshetty; S Pallad; D D Deshpande; S K Shrivastava; K A Dinshaw
Journal:  J Med Phys       Date:  2008-01

10.  Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.

Authors:  Cem Onal; Gungor Arslan; Erkan Topkan; Berrin Pehlivan; Melek Yavuz; Ezgi Oymak; Aydin Yavuz
Journal:  J Exp Clin Cancer Res       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.